| Date Filed | Type | Description |
| 05/30/2023 |
SC 13G/A
| Bain Capital Life Sciences Fund, L.P. reports a 5.5% stake in Annexon, Inc. |
| 02/14/2023 |
SC 13G/A
| Bain Capital Life Sciences Fund, L.P. has filed a Schedule 13D for Annexon, Inc. |
| 02/14/2023 |
SC 13G/A
| Bain Capital Life Sciences Fund, L.P. has filed a Schedule 13D for X4 Pharmaceuticals, Inc. |
| 08/17/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/08/2022 |
SC 13D/A
| Bain Capital Life Sciences Fund, L.P. reports a 4.5% stake in ARCUTIS BIOTHERAPEUTICS, INC. |
| 05/27/2022 |
SC 13D/A
| Bain Capital Life Sciences Fund, L.P. reports a 5.3% stake in ARCUTIS BIOTHERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G/A
| Bain Capital Life Sciences Fund, L.P. has filed a Schedule 13D for X4 Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/27/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/11/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/11/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/26/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/19/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G
| Bain Capital Life Sciences Fund, L.P. reports a 7.7% stake in Annexon, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2021 |
SC 13D/A
| Bain Capital Life Sciences Fund, L.P. reports a 7.4% stake in Arcutis Biotherapeutics, Inc. |
| 12/14/2020 |
SC 13D/A
| Bain Capital Life Sciences Fund, L.P. reports a 3.7% stake in Dicerna Pharmaceuticals, Inc. |
| 10/27/2020 |
SC 13D/A
| Bain Capital Life Sciences Fund, L.P. reports a 13.3% stake in Aptinyx Inc. |
| 05/28/2020 |
SC 13D/A
| Bain Capital Life Sciences Fund, L.P. reports a 14% stake in Dynavax Technologies Corporation |
| 03/12/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2020 |
SC 13D
| Bain Capital Life Sciences Fund, L.P. reports a 9.5% stake in Arcutis Biotherapeutics, Inc. |
| 01/16/2020 |
SC 13D/A
| Bain Capital Life Sciences Fund, L.P. reports a 11.1% stake in Aptinyx Inc. |
| 12/09/2019 |
SC 13G
| Bain Capital Life Sciences Fund, L.P. has filed a Schedule 13D for X4 Pharmaceuticals, Inc. |
| 12/06/2019 |
SC 13D/A
| Bain Capital Life Sciences Fund, L.P. reports a 5.4% stake in Dicerna Pharmaceuticals, Inc. |
| 11/21/2019 |
SC 13D/A
| Bain Capital Life Sciences Fund, L.P. reports a 7.4% stake in Dicerna Pharmaceuticals, Inc. |
| 10/11/2019 |
SC 13G
| Bain Capital Life Sciences Fund, L.P. reports a 7.7% stake in Constellation Pharmaceuticals, Inc. |
| 08/22/2019 |
SC 13D
| Bain Capital Life Sciences Fund, L.P. reports a 14% stake in Dynavax Technologies Corporation |
| 05/31/2019 |
SC 13D/A
| Bain Capital Life Sciences Fund, L.P. reports a 9.7% stake in Dicerna Pharmaceuticals, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/01/2018 |
SC 13G
| Bain Capital Life Sciences Fund, L.P. reports a 8.2% stake in Replimune Group, Inc. |
| 07/03/2018 |
SC 13D
| Bain Capital Life Sciences Fund, L.P. reports a 6.2% stake in Aptinyx Inc. |
|